0 Évaluations
ID

40391

Description

Performance of a Tablet Based Workflow and Decision Support System With Incorporated Software Algorithm Used for Glycaemic Management; ODM derived from: https://clinicaltrials.gov/show/NCT01766752

Lien

https://clinicaltrials.gov/show/NCT01766752

Mots-clés

Versions (3)
  1. 19/01/2019 19/01/2019 -
  2. 17/04/2020 17/04/2020 -
  3. 17/04/2020 17/04/2020 - Sarah Riepenhausen
Détendeur de droits

Medical University of Graz

Téléchargé le

17 avril 2020

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

    Aucun commentaire

    Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

    Eligibility Type 2 Diabetes NCT01766752

    Anglais

    Eligibility Type 2 Diabetes NCT01766752

    1 Formulaires  
    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    informed consent obtained after being advised of the nature of the study
    Description

    Informed consent

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    male or female aged 18 - 90 years (both inclusive)
    Description

    Age

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0001779
    type 2 diabetes treated with diet, oral agents, non-insulin injected anti-diabetic medicine, insulin therapy or any combination of the four
    Description

    Type 2 DM treated with: diet, oral or injected antidiabetics, insulin, single or combined

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0011860
    UMLS CUI [2]
    C0011878
    UMLS CUI [3,1]
    C0935929
    UMLS CUI [3,2]
    C1527415
    UMLS CUI [4,1]
    C0935929
    UMLS CUI [4,2]
    C1828121
    UMLS CUI [5]
    C0021641
    UMLS CUI [6,1]
    C3274787
    UMLS CUI [6,2]
    C0205195
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    impaired renal function (serum creatinine ≥3.0mg/dl)
    Description

    Renal insufficiency Creatinine measurement (serum)

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C1565489
    UMLS CUI [1,2]
    C0201976
    any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the patient
    Description

    Disease interferes with study protocol | Disease risk for patient safety

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0012634
    UMLS CUI [1,2]
    C0521102
    UMLS CUI [1,3]
    C2348563
    UMLS CUI [2,1]
    C0012634
    UMLS CUI [2,2]
    C0035647
    UMLS CUI [2,3]
    C1113679
    pregnancy
    Description

    Pregnancy

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0032961
    any mental condition rendering the patient incapable of giving his consent
    Description

    Mental disorder | Informed Consent incapable

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0004936
    UMLS CUI [1,2]
    C0021430
    UMLS CUI [1,3]
    C1550518
    terminally ill patients
    Description

    Terminal illness

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0679247
    participation in a trial within 3 months prior to this trial
    Description

    Recent trial participation

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C2348568
    UMLS CUI [1,2]
    C0332185
    known or suspected allergy to insulin
    Description

    Insulin allergy, known or suspected

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0571622
    UMLS CUI [2,1]
    C0571622
    UMLS CUI [2,2]
    C0750491
    Retour au début de la page

    Similar models

    Eligibility Type 2 Diabetes NCT01766752

    1 Formulaires
    Name
    Type
    Description | Question | Decode (Coded Value)
    Type de données
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Informed consent
    Item
    informed consent obtained after being advised of the nature of the study
    boolean
    C0021430 (UMLS CUI [1])
    Age
    Item
    male or female aged 18 - 90 years (both inclusive)
    boolean
    C0001779 (UMLS CUI [1])
    Type 2 DM treated with: diet, oral or injected antidiabetics, insulin, single or combined
    Item
    type 2 diabetes treated with diet, oral agents, non-insulin injected anti-diabetic medicine, insulin therapy or any combination of the four
    boolean
    C0011860 (UMLS CUI [1])
    C0011878 (UMLS CUI [2])
    C0935929 (UMLS CUI [3,1])
    C1527415 (UMLS CUI [3,2])
    C0935929 (UMLS CUI [4,1])
    C1828121 (UMLS CUI [4,2])
    C0021641 (UMLS CUI [5])
    C3274787 (UMLS CUI [6,1])
    C0205195 (UMLS CUI [6,2])
    Item Group
    C0680251 (UMLS CUI)
    Renal insufficiency Creatinine measurement (serum)
    Item
    impaired renal function (serum creatinine ≥3.0mg/dl)
    boolean
    C1565489 (UMLS CUI [1,1])
    C0201976 (UMLS CUI [1,2])
    Disease interferes with study protocol | Disease risk for patient safety
    Item
    any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the patient
    boolean
    C0012634 (UMLS CUI [1,1])
    C0521102 (UMLS CUI [1,2])
    C2348563 (UMLS CUI [1,3])
    C0012634 (UMLS CUI [2,1])
    C0035647 (UMLS CUI [2,2])
    C1113679 (UMLS CUI [2,3])
    Pregnancy
    Item
    pregnancy
    boolean
    C0032961 (UMLS CUI [1])
    Mental disorder | Informed Consent incapable
    Item
    any mental condition rendering the patient incapable of giving his consent
    boolean
    C0004936 (UMLS CUI [1,1])
    C0021430 (UMLS CUI [1,2])
    C1550518 (UMLS CUI [1,3])
    Terminal illness
    Item
    terminally ill patients
    boolean
    C0679247 (UMLS CUI [1])
    Recent trial participation
    Item
    participation in a trial within 3 months prior to this trial
    boolean
    C2348568 (UMLS CUI [1,1])
    C0332185 (UMLS CUI [1,2])
    Insulin allergy, known or suspected
    Item
    known or suspected allergy to insulin
    boolean
    C0571622 (UMLS CUI [1])
    C0571622 (UMLS CUI [2,1])
    C0750491 (UMLS CUI [2,2])
    Retour au début de la page 

    Aide

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial